A new survey of New Jersey's biotech industry has found that the drug development business is growing steadily. Combined public and private biotech revenue was set at $5 billion from 238 biotech companies in the state--up from 226 in 2006. And 86 percent of the surveyed companies said they expect to hire 20 or more employees in the next 12 months. Report